Skip to main content
. 2015 Mar 4;6(5):491–495. doi: 10.1021/acsmedchemlett.5b00037

Table 1. EPZ011989 in Vitro Data Summary.

property analysis units EPZ011989
EZH2 activity biochemical Ki nM <3 (WT) <3 (Y646)
ELISA H3K27me3 IC50a nM 94 ± 48 (n = 20)
liver microsome clearance scaled microsomal clearanceb mL/min/kg (%Eh)c human 6 ± 0.5(29)
rat <10(<14)
mouse <10(<11)
plasma protein binding equilibrium dialysis percent unbound human 97 ± 3
rat 91 ± 6
mouse 80 ± 11
LCC 11d proliferation WSU-DLCL2 nM 208 ± 75 (n = 4)
predicted efficacious plasma exposured nM (ng/mL) human 214(130)
rat 223(135)
mouse 260(158)
a

Enzyme-linked immunoassay measure of cellular methyl mark reduction.

b

Scaled according to the well-stirred liver model.

c

Percent hepatic extraction.

d

Plasma protein binding corrected LCC.